Treatment of "minimal brain dysfunction" syndromes. Selection of drugs for children with hyperactivity and learning disabilities.
D000661:Amphetamine / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D001925:Brain Damage, Chronic / Q000188:drug therapy*; D002648:Child; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003642:Deanol / Q000627:therapeutic use; D006801:Humans; D007859:Learning Disabilities / Q000188:drug therapy*; D008774:Methylphenidate / Q000627:therapeutic use; D009069:Movement Disorders / Q000188:drug therapy*; D010919:Placebos; D012110:Reserpine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000927:Anticonvulsants; D010919:Placebos; D014149:Tranquilizing Agents; D008774:Methylphenidate; D003642:Deanol; D002707:Chlordiazepoxide; D012110:Reserpine; D000661:Amphetamine; D002746:Chlorpromazine